`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`C.A. No. 22-252 (MSG)
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GmbH,
`
`Plaintiffs,
`
`v.
`
`MODERNA, INC. and MODERNATX, INC.
`
`Defendants.
`MODERNA, INC. and MODERNATX, INC.,
`
`Counterclaim-Plaintiffs,
`
`v.
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GmbH,
`
`Counterclaim-Defendants.
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`
`ORDER
`
`The Court, having considered Moderna’s Omnibus Motion to Seal (the “Motion”), IT IS
`
`20
`HEREBY ORDERED this day of
`
`May
` , 2024 that the Motion is GRANTED.
`
`Leave is given for Moderna to file Plaintiffs’ Letter Brief in Support of Plaintiffs’ Motion
`
`for Leave to Amend Complaint and the exhibits thereto (D.I. 278); Plaintiffs’ Letter Brief in
`
`Support of Plaintiffs’ Motion to Compel and the exhibits thereto (D.I. 285); Moderna’s Opposition
`
`to Plaintiffs’ Motion to Compel Bancel Documents and the exhibits thereto (D.I. 294); and
`
`Moderna’s Opposition to Plaintiffs’ 30(b)(6) Motion to Compel and the exhibit thereto (D.I. 302)
`
`in redacted form.
`
`/s/ Mitchell S. Goldberg
`__________________________
`United States District Judge
`
`